Clinical trial Recruiting at 1 site Interventional Ages 18 and up Men only

Online support for men adjusting to prostate cancer

Official title: Internet-based Support for Adjustment to Prostate Cancer (ISAC) - A Randomized Controlled Trial of ICBT for Distress Related to Prostate Cancer

Run by Linkoeping University · NCT06766526 · Data updated 2026-11-12

This study is testing if an online therapy program can help men dealing with emotional challenges after being diagnosed with prostate cancer.

Quick facts

Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment180 (estimated)
SponsorLinkoeping University
Government
Locations1 site (Linköping)
StatusRecruiting
StartedJanuary 5, 2025
Main results expectedJune 2026
Study endsDecember 2026
Registry record updatedFebruary 24, 2025
Trial IDNCT06766526 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men aged 18 or older who have been diagnosed with prostate cancer and are experiencing psychological symptoms related to their diagnosis.

Probably not a fit

Patients currently undergoing medical treatment for prostate cancer or those with severe psychiatric conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of internet-based cognitive behavior therapy (ICBT) in alleviating psychological distress and related psychiatric symptoms in men diagnosed with prostate cancer. Participants will be randomly assigned to either an eight-week tailored ICBT intervention or an attention control group, both receiving weekly support from a trained therapist. The primary focus is on reducing psychological distress, with additional health-related outcomes also being assessed. Recruitment will take place across Sweden, targeting men who are not currently undergoing medical treatment for prostate cancer.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the mental health and quality of life for men coping with prostate cancer.

How similar studies have gone: Previous studies have shown that internet-based cognitive behavioral therapy can be effective for various psychological issues, suggesting potential success for this tailored approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjectively reported psychological symptoms and problems that have come about after a prostate cancer diagnosis.
* A sum score above 19 on the primary outcome measure (Kessler-10).
* An age of 18 or older.
* Ability to speak, read, and write Swedish.
* Access to a computer/laptop/tablet/smartphone and internet access.
* Sufficient computer profiency to be able to use the treatment platform.

Exclusion Criteria:

* Planned medical treatment or planned change in medication related to the prostate cancer during the treatment period.
* Recently finished (within the past six months) medical treatment for prostate cancer.
* Severe psychiatric or somatic conditions that impedes participation in the study.
* Ongoing substance use problems.
* Acute suicidality.
* Other ongoing psychological treatment.
* Psychopharmaceutic treatment that has been changed within the past month or with planned changes during the treatment phase.

Where it's running

  • Department of Behavioral Sciences and Learning
    Linköping, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.